FNKCX
Price
$17.00
Change
+$0.10 (+0.59%)
Updated
Aug 21 closing price
Net Assets
35.05M
JVMSX
Price
$31.97
Change
+$0.22 (+0.69%)
Updated
Aug 21 closing price
Net Assets
24.14B
Interact to see
Advertisement

FNKCX vs JVMSX

FNKCX vs JVMSX Comparison Chart in %
View a ticker or compare two or three
VS
FNKCX vs. JVMSX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNKCX is a StrongBuy and JVMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 24.1B vs. FNKCX (35M). FNKCX pays higher dividends than JVMSX: FNKCX (0.51) vs JVMSX (0.34). FNKCX was incepted earlier than JVMSX: FNKCX (16 years) vs JVMSX (14 years). FNKCX (1.99) is less costly to investors than JVMSX (1.25). FNKCX is a more actively managed with annual turnover of: 105.26 vs. JVMSX (48.00). JVMSX has a lower initial minimum investment than FNKCX: JVMSX (0) vs FNKCX (1500). JVMSX annual gain was more profitable for investors over the last year : 10.13 vs. FNKCX (4.78). FNKCX return over 5 years is better than : 31.97 vs. JVMSX (18.29).
FNKCXJVMSXFNKCX / JVMSX
Total Expense Ratio1.991.24160%
Annual Report Gross Expense Ratio1.991.25159%
Fund Existence16 years14 years-
Gain YTD18.71517.063110%
Front LoadN/AN/A-
Min. Initial Investment15000-
Min. Initial Investment IRAN/AN/A-
Net Assets35M24.1B0%
Annual Yield % from dividends0.510.34151%
Returns for 1 year4.7810.1347%
Returns for 3 years34.5326.24132%
Returns for 5 years31.9718.29175%
Returns for 10 years38.1958.0766%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SUHCX24.260.29
+1.21%
DWS Health and Wellness C
BROCX24.340.25
+1.04%
BlackRock Advantage International Inv C
NBFAX36.200.25
+0.70%
Neuberger Focus Adv
SIIIX16.390.01
+0.06%
AlphaCentric Real Income I
FITIX27.21N/A
N/A
Fidelity Advisor Mid Cap II M